LPTI Longport Inc (CE)

Longport, Inc., (OTC BB: LPTI), a medical technology specialist in high resolution ultrasound imaging, announced that it has signed distribution agreements with three companies: Specialty Medical Products, Malvern, PA.; Heritage Medical Products, Lancaster, Ohio; and All Imaging Systems, Irvine, California. John Calabrese, Director of Sales and Marketing of Longport, "The addition of these three experienced organizations improves our coverage in Pennsylvania, Delaware, New Jersey, and establishes our presence in Ohio, Southern California and Nevada. These distributors will all be active in wound care as well as the aesthetic and dermatology markets." Bud Harris, CEO of Specialty Medical Products, stated, "We are delighted to add the Episcan I-200 to the group of technical products we offer to our customers in the long term care sector. In particular, it complements a number of our existing products and we have already generated significant interest in the marketplace in the Scanner." Mike Wardell, Director of Sales for All Imaging Inc., remarked that their management team "is proud to represent Longport Inc. in the Southern California market. We pride ourselves in offering a wide range of ultrasound products and the expertise to provide excellent maintenance for these products. The addition of the Longport, Inc. high frequency ultrasound system, allows us to now provide our customers with a unique diagnostic solution for clinical problems associated with a wide range of disciplines including, dermatology, wound care, plastic surgery and aesthetics. We expect 2006 to be a big year for the Longport and All Imaging relationship." John Calabrese added, "Once these new distributors have been trained by Longport clinical personnel, we will have seven active distributors with approximately 50 sales representatives operating in 13 states. In addition, we continue to have discussions with several other organizations that we hope to add to our distribution network in the near future." About Longport, Inc. Longport, Inc. of Glen Mills, Pennsylvania, is a medical technology company that specializes in high resolution ultrasound imaging. After several years and a multi-million dollar investment in the technology, Longport has secured patents, copyrights, and FDA permission to market. The Company's technology has been used to engineer a unique high resolution ultrasound imaging system. For further information please contact Longport, Inc. at 1-800-289-6863 or visit our website at www.longportinc.com. Forward-looking Information and the Private Securities Litigation Reform Act of 1995 Certain statements in this press release, including statements concerning product development milestones and anticipated events, are "forward-looking statements" within the Private Litigation Reform Act of 1995. Forward Looking Statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect Longport's actual results include, among others, uncertainties as to the Company's ability to manage potential problems, delays or anticipated expenses, including problems, delays or expenses involving manufacturing. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only to the date of this release. Reference is made to Longport's 2004 annual report on Form 10-K filed with the Securities and Exchange Commission for a more definitive description of such factors. Longport, Inc. undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.